OPEN-LABEL, MULTICENTER, DOSE-ESCALATING PHASE II CLINICAL TRIAL ON THE SAFETY AND EFFICACY OF TADEKINIG ALPHA IN ADULT ONSET STILL'S DISEASE - Gabay, C.; Fautrel, B.; Rech, Jürgen; Spertini, F.; Feist, E.; Koetter, I.; Hachulla, E.; Morel, J.; Schaeverbeke, T.; Hamidou, M. A.; Martin, T.; Hellmich, B.; et al. (2017)
EVALuna2:35032